Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Inverseon, Inc. University of Houston Sandler Program for Asthma Research Baylor College of Medicine |
---|---|
Information provided by: | Inverseon, Inc. |
ClinicalTrials.gov Identifier: | NCT00670267 |
The purpose of this study is to confirm previous observations in asthmatics that chronic nadolol treatment reduces asthmatic airway hyper-responsiveness.
Condition | Intervention | Phase |
---|---|---|
Asthma |
Drug: nadolol |
Phase I Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Dose Comparison, Single Group Assignment, Safety/Efficacy Study |
Official Title: | An Open-Label, Dose-Escalating, Study to Evaluate the Safety, Efficacy and Tolerability of Oral Nadolol for the Treatment of Adults With Mild Asthma |
Estimated Enrollment: | 10 |
Study Start Date: | January 2007 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Texas | |
Baylor College of Medicine | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Benil Mannava mannava@bcm.tmc.edu | |
Principal Investigator: Nick Hanania, M.D. |
Responsible Party: | The Baylor College of Medicine ( Professor Nick Hanania, M.D. ) |
Study ID Numbers: | SAND1002 |
Study First Received: | April 29, 2008 |
Last Updated: | May 5, 2008 |
ClinicalTrials.gov Identifier: | NCT00670267 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Asthma hyperresponsiveness |
Neurotransmitter Agents Bronchial Diseases Adrenergic Agents Asthma Nadolol Cardiovascular Agents Antihypertensive Agents Lung Diseases, Obstructive Hypersensitivity |
Respiratory Tract Diseases Lung Diseases Hypersensitivity, Immediate Adrenergic beta-Antagonists Adrenergic Antagonists Peripheral Nervous System Agents Anti-Arrhythmia Agents Respiratory Hypersensitivity |
Sympatholytics Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Bronchial Diseases Immune System Diseases Adrenergic Agents Physiological Effects of Drugs Asthma Nadolol Cardiovascular Agents Antihypertensive Agents Pharmacologic Actions |
Lung Diseases, Obstructive Hypersensitivity Respiratory Tract Diseases Autonomic Agents Therapeutic Uses Lung Diseases Hypersensitivity, Immediate Adrenergic beta-Antagonists Adrenergic Antagonists Peripheral Nervous System Agents Anti-Arrhythmia Agents Respiratory Hypersensitivity |